Mounjaro Injection, Solution
Product Images NDC 50090-8023

Product Visual Gallery

This gallery contains 64 technical images submitted to the FDA as part of the official labeling for Mounjaro (NDC 50090-8023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500908023)

MOUNJARO 7.5 mg/0.5 mL tirzepatide injection solution in a 4.5 mL prefilled pen. Label indicates subcutaneous route, storage instructions to keep at 36 to 46 degrees Fahrenheit, and protection from light. Manufactured by A-S Medication Solutions with product NDC 50090-8023.*

FDA Label Image

Figure (Logo)

FDA Label Image

Figure (Moun Pen Ifu 1 V3)

MOUNJARO 7.5 mg/0.5 mL injection solution in a subcutaneous pen device. The image shows a single-dose pen injector with a clear needle shield, a white body with gray and green markings, and a purple cap at the end. Labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Moun Pen Ifu 10 V2)

An instructional diagram showing the gray plunger inside the lower part of a syringe. The image highlights the plunger component as part of the injection device for the medication.*

FDA Label Image

Figure (Moun Pen Ifu 2 V2)

An instructional diagram of the MOUNJARO 7.5 mg/0.5 mL injection pen showing labeled parts including the purple injection button at the top, lock ring and indicator on the upper body, lock/unlock mechanism, medicine reservoir, clear base, gray base cap, and needle end at the bottom. The diagram includes directional arrows indicating the top and bottom of the pen.*

FDA Label Image

Figure (Moun Pen Ifu 3 V2)

An illustration showing a close-up view of a MOUNJARO injection pen with a labeled indicator pointing to the location of the expiration date on the pen's body. The expiration date is highlighted within a black rectangular area near the middle of the pen.*

FDA Label Image

Figure (Moun Pen Ifu 4a V1)

An illustration showing a human torso with highlighted injection site areas in purple. The depicted injection sites include the abdomen around the navel and the front of the thighs, indicating appropriate subcutaneous injection locations for the medication.*

FDA Label Image

Figure (Moun Pen Ifu 4b V1)

An instructional diagram showing the recommended subcutaneous injection sites on the upper outer arms of a human figure. The areas suitable for injection are highlighted in purple on both arms, indicating proper locations for administering the MOUNJARO (tirzepatide) injection solution.*

FDA Label Image

Figure (Moun Pen Ifu 5 V2)

Illustration showing the steps to remove the gray base cap from the clear base of a MOUNJARO (tirzepatide) 7.5 mg/.5 mL subcutaneous injection pen. The diagram highlights a locked position on the pen and demonstrates how to pull off the gray base cap from the pen's clear base.*

FDA Label Image

Figure (Moun Pen Ifu 6 V2)

Illustration showing an individual injecting a subcutaneous injection into the abdominal area using a pen-type injector device. The figure demonstrates proper injection technique with the device held in one hand and positioned near the skin on the belly.*

FDA Label Image

Figure (Moun Pen Ifu 7 V2)

An instructional illustration showing a hand holding an injectable pen device. The image emphasizes a twisting motion to unlock the device cap, indicated by a red arrow and an open padlock icon, highlighting the step to prepare the injection pen for use.*

FDA Label Image

Figure (Moun Pen Ifu 8 V2)

An instructional illustration showing a hand holding a MOUNJARO injection pen near the abdomen, demonstrating the subcutaneous injection procedure for the tirzepatide solution.*

FDA Label Image

Figure (Moun Pen Ifu 9 V2)

An instructional diagram showing a close-up of a syringe component with a red arrow pointing to the gray plunger. The image highlights the gray plunger inside the syringe assembly, likely for user guidance on the injection device.*

FDA Label Image

Figure (Moun Qr)

FDA Label Image

Structural Formula (Moun Uspi Chem Struc)

Chemical structure diagram of tirzepatide, showing its peptide backbone with amino acid sequence and attached side chains. The image depicts detailed molecular connections typical of a complex peptide drug molecule.*

FDA Label Image

Figure 1 (Moun Uspi F1 V1)

A line graph showing insulin levels (mIU/L) over time (minutes) during a two-phase study. It compares placebo baseline, placebo at week 28, tirzepatide 15 mg baseline, and tirzepatide 15 mg at week 28, highlighting increased insulin levels for tirzepatide at week 28 versus other conditions.*

FDA Label Image

Figure 2 (Moun Uspi F2 V1)

A line graph showing HbA1c percentage over time in weeks post-randomization for different doses of MOUNJARO (5 mg, 10 mg, 15 mg) compared to Semaglutide 1 mg. The graph plots HbA1c (%) on the y-axis and weeks on the x-axis, illustrating HbA1c trends up to week 40 for each treatment group.*

FDA Label Image

Figure (Moun Vial Ifu 1 V1)

An illustration diagram showing a vial labeled MOUNJARO tirzepatide injection. The diagram highlights key parts of the vial: the protective cap and a rubber stopper under the cap. The vial contains the injectable solution for subcutaneous use.*

FDA Label Image

Figure (Moun Vial Ifu 10 V1)

An instructional illustration showing a hand holding a vial and another hand holding a syringe, with an arrow indicating the direction to insert the syringe needle into the vial for medication preparation or withdrawal.*

FDA Label Image

Figure (Moun Vial Ifu 11 V1)

A black and white instructional illustration showing hands drawing medication from a vial into a syringe, indicating the process of preparing an injection. An arrow suggests the motion of pulling the syringe plunger back to draw the liquid.*

FDA Label Image

Figure (Moun Vial Ifu 12 V1)

An instructional illustration showing a hand holding a syringe with the needle inserted into the forearm, accompanied by a close-up view of the syringe barrel marked with volume measurements from 0.1 to 0.6 mL, indicating an injection volume of 0.5 mL. This likely demonstrates the subcutaneous injection process for MOUNJARO (tirzepatide) injection solution.*

FDA Label Image

Figure (Moun Vial Ifu 13 V1)

An instructional illustration depicting two hands preparing an injection using a syringe and vial. One hand holds the vial upside down while the other hand pulls the syringe plunger to draw the medication into the syringe, demonstrating the preparation of a subcutaneous injection.*

FDA Label Image

Figure (Moun Vial Ifu 14 V1)

An instructional diagram showing a person holding a syringe and vial. The image includes a close-up of the syringe barrel with volume markings from 0.1 to 0.5 mL, with an arrow indicating upward movement, suggesting the drawing of medication from the vial into the syringe.*

FDA Label Image

Figure (Moun Vial Ifu 15 V1)

An instructional illustration showing a hand holding a vial and another hand holding a syringe. An arrow indicates drawing liquid from the vial into the syringe, demonstrating preparation of an injection.*

FDA Label Image

Figure (Moun Vial Ifu 16 V1)

An anatomical illustration of a human torso and upper legs highlighting recommended injection sites for subcutaneous administration. The image marks the abdomen area around the navel and the front of both thighs as injection locations.*

FDA Label Image

Figure (Moun Vial Ifu 17 V1)

An illustration showing the back view of a human figure highlighting areas on both upper arms. The shaded regions indicate proper subcutaneous injection sites for administering medication, demonstrating recommended locations for injection placement on the arms.*

FDA Label Image

Figure (Moun Vial Ifu 18 V1)

An instructional illustration showing a person administering a subcutaneous injection in the abdomen area. The person's hand holds a syringe or injection device near the lower stomach, with an arrow indicating the injection direction.*

FDA Label Image

Figure (Moun Vial Ifu 19 V1)

An instructional illustration showing the proper technique for administering a subcutaneous injection into the abdomen. The image depicts a hand holding a syringe at an angle, inserting the needle into the abdominal area just above the waistband.*

FDA Label Image

Figure (Moun Vial Ifu 2 V1)

An instructional diagram of a syringe assembly showing labeled parts including Needle Shield, Needle, Syringe Body with volume markings in milliliters, Plunger Tip, and Plunger. An enlarged view highlights the 0.5 mL measurement on the syringe scale.*

FDA Label Image

Figure (Moun Vial Ifu 20 V1)

An instructional illustration showing a person administering a subcutaneous injection in the area below the neck. The drawing highlights the correct needle insertion angle and placement for self-injection using a syringe, likely related to the medication MOUNJARO (tirzepatide) injection, solution 7.5 mg/.5 mL.*

FDA Label Image

Figure (Moun Vial Ifu 3 V1)

An instructional illustration depicting two hands; one hand holds a vial while the other hand is shown lifting or removing the cap from the vial. The image includes an upward pointing arrow to indicate the direction in which to pull the vial cap.*

FDA Label Image

Figure (Moun Vial Ifu 4 V1)

An instructional illustration showing hands preparing a small vial by peeling off the vial cap. The image suggests a step in medication preparation, likely for injectable solution administration.*

FDA Label Image

Figure (Moun Vial Ifu 5 V1)

An instructional line art illustration showing hands preparing a syringe with a solution drawn from an injection pen or vial, depicting part of the process for administering a subcutaneous injection.*

FDA Label Image

Figure (Moun Vial Ifu 6 V1)

An instructional line drawing illustrating a person peeling an adhesive label or backing from an injection device, demonstrating preparation steps for using a subcutaneous injection.*

FDA Label Image

Figure (Moun Vial Ifu 7 V1)

An instructional diagram illustrating how to apply or secure an adhesive strip or tape around a cylindrical object, possibly related to administration or handling of an injectable solution device.*

FDA Label Image

Figure (Moun Vial Ifu 8 V1)

An instructional illustration showing two hands holding a syringe. The left hand holds the cap, which is being pulled off the syringe in the direction of the gray arrow pointing left.*

FDA Label Image

Figure (Moun Vial Ifu 9 V1)

An instructional illustration showing a hand holding a syringe with the plunger being pushed downward. A close-up inset displays the syringe barrel with volume markings from 0.1 to 0.5 mL, indicating fluid measurement inside the syringe.*

FDA Label Image

Figure (Moun Vial Md Ifu 14 V1)

An instructional illustration showing hands drawing a solution into a syringe from a vial. The syringe is marked with volume measurements from 0.1 to 0.6 mL, with the liquid level near the 0.5 mL mark. An upward arrow indicates the direction of drawing the solution into the syringe.*

FDA Label Image

Figure (Moun Vial Md Ifu 2 V1)

An instructional diagram of a syringe labeled with its parts including needle shield, needle, plunger tip, plunger, and syringe body. The syringe body is marked with volume graduations from 0.1 to 1.0 mL, with a magnified inset highlighting the 0.5 to 0.7 mL markings.*

FDA Label Image

Figure (Moun Vial Md Ifu 9 V1)

An instructional illustration showing hands holding a syringe. One hand is pulling a plunger downward, indicated by an arrow. A close-up view of the syringe barrel shows measurement marks from 0.1 to 0.6 mL, suggesting dose preparation or adjustment.*

FDA Label Image

Figure (Mounjaro Kp 1 Pen V1)

The image shows a MOUNJARO 7.5 mg/.5mL injection pen for subcutaneous use. The device is white with a purple cap on one end and a gray clip on the side. It is a solution dosage form labeled by A-S Medication Solutions. The pen is designed for human prescription drug administration.*

FDA Label Image

Figure (Mounjaro Kp 10 Dial Clicks V1)

An instructional illustration showing a hand peeling back a rectangular adhesive label from a surface, indicating a step in using or preparing a medical device or injectable product.*

FDA Label Image

Figure (Mounjaro Kp 11 Dial Zoom V1)

MOUNJARO 7.5 mg/0.5 mL injection, solution for subcutaneous use, packaged in a box containing 4 single-dose pens. The label shows the proprietor name A-S Medication Solutions and includes dosing and storage information, along with an illustration of the pen injector.*

FDA Label Image

Figure (Mounjaro Kp 12 Tap V1)

An instructional illustration showing a close-up of a hand holding a subcutaneous injection pen and a finger pointing to the pen's plunger, accompanied by a red arrow indicating the direction to push the plunger for injection.*

FDA Label Image

Figure (Mounjaro Kp 13 5sec Hold V1)

An instructional illustration showing a hand holding a syringe with a safety cap being removed by pulling upward. The inset highlights the top of the syringe with the safety cap being taken off. A stopwatch icon suggests timing or readiness for use after cap removal.*

FDA Label Image

Figure (Mounjaro Kp 14 Zero Dial Zoom V1)

The image shows a MOUNJARO 7.5 mg/0.5 mL injection solution carton for subcutaneous use. It is labeled as a human prescription drug containing the active ingredient tirzepatide. The labeler is A-S Medication Solutions. The packaging appears white with green and black text, including dosage and administration information.*

FDA Label Image

Figure (Mounjaro Kp 15 Inj Sites V1)

An instructional diagram showing recommended subcutaneous injection sites for MOUNJARO (tirzepatide) injection solution 7.5 mg/.5 mL. Highlighted areas include the abdomen, front of the thigh, and upper arm on a simplified human figure viewed from front and back.*

FDA Label Image

Figure (Mounjaro Kp 16 Dial 1 Dose V1)

An instructional illustration showing how to dial the dose on a MOUNJARO 7.5 mg/0.5 mL subcutaneous injection pen. The image depicts a hand turning the dose dial on the injection device, with arrows indicating the dialing direction.*

FDA Label Image

Figure (Mounjaro Kp 17 Dial 1 Zoom V1)

MOUNJARO 7.5 mg/.5 mL subcutaneous injection solution. The image shows a small rectangular carton with the brand name MOUNJARO prominently displayed. The label indicates the active ingredient tirzepatide and strength 7.5 mg per 0.5 mL. The labeler is A-S Medication Solutions and the product NDC is 50090-8023.*

FDA Label Image

Figure (Mounjaro Kp 18 Insert Needle V1)

An instructional illustration showing a hand holding an injection pen near a bent arm, with an arrow indicating the direction to administer a subcutaneous injection.*

FDA Label Image

Figure (Mounjaro Kp 19 Push Hold V1)

Instructional illustration showing a hand holding a MOUNJARO injection pen against a thigh with an arrow labeled 'PUSH' indicating injection. A stopwatch icon with '5 sec. HOLD' directs the user to hold the injection for five seconds after pushing.*

FDA Label Image

Figure (Mounjaro Kp 2 Pen Parts V2)

An instructional diagram of the components of a MOUNJARO tirzepatide injection pen and pen needle. It labels parts including the pen cap with clip, cartridge with red inner seal, plunger, cartridge holder, pen body with label, dose indicator within a dose window, and dose knob. Separately, it shows pen needle parts without needles: outer needle shield, inner needle shield, needle, and paper tab.*

FDA Label Image

Figure (Mounjaro Kp 20 Remove V1)

An instructional illustration showing a person administering a subcutaneous injection to the abdomen using a prefilled injection pen. The image includes an arrow indicating the motion direction for the injection.*

FDA Label Image

Figure (Mounjaro Kp 21 Cotton Ball V1)

An instructional illustration showing a hand pinching the skin on the abdomen to prepare the area for a subcutaneous injection. An arrow points to the injection site on the abdomen, indicating where to administer the injection.*

FDA Label Image

Figure (Mounjaro Kp 22 Recap Shield V1)

An instructional illustration showing a hand holding a pen-type injection device with the needle cap being removed. A red arrow indicates the direction to pull off the needle cap before injection.*

FDA Label Image

Figure (Mounjaro Kp 23 Remove Needle V1)

An instructional illustration showing a hand removing a protective cap from a pen injector device, with a red arrow indicating the direction to pull the cap off the device tip.*

FDA Label Image

Figure (Mounjaro Kp 24 Recap Pen V1)

An instructional illustration showing the removal of a protective cap from a syringe, depicted with an arrow indicating the direction to pull the cap off the needle end of the device.*

FDA Label Image

Figure (Mounjaro Kp 3 Wash V1)

An instructional illustration showing two hands being washed with soap bubbles around them, indicating a handwashing step.*

FDA Label Image

Figure (Mounjaro Kp 4 Uncap V1)

An illustration showing a capped injection pen with an arrow pointing left, indicating removal of the cap from the device. The image is instructional, likely demonstrating how to prepare the injection pen for use.*

FDA Label Image

Figure (Mounjaro Kp 5 Wipe V1)

An instructional illustration showing a person removing the cap from a vial or tube by rotating and pulling it off, indicated by a red arrow. The image depicts hand positioning during the cap removal process.*

FDA Label Image

Figure (Mounjaro Kp 6 New Needle Tab V1)

An instructional diagram showing a hand holding a pen-like device with the thumb pressing down on the top, while the other hand holds a small round cap or cover being lifted or removed with an upward red arrow indicating the direction to remove the cap.*

FDA Label Image

Figure (Mounjaro Kp 7 Attach Needle V1)

An instructional illustration showing the proper technique for attaching or securing a cap or connector to a cylindrical injection device. The image features red arrows indicating a twisting motion to align or lock components of the device.*

FDA Label Image

Figure (Mounjaro Kp 8 Outer Shield V1)

An instructional diagram showing how to remove a cap from a needle or injection device by pulling it straight upward, indicated by a red arrow pointing up.*

FDA Label Image

Figure (Mounjaro Kp 9 Inner Shield V1)

An instructional illustration showing the removal of a needle cap from an injection pen. The image depicts a hand or object lifting a needle cap straight upward away from the injection device.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.